Palatin Technologies 

$5.35
150
-$0.78-12.65% 20:54 Today

Statistics

Day High
6.15
Day Low
5.26
52W High
31
52W Low
4.51
Volume
674
Avg. Volume
-
Mkt Cap
9.53M
P/E Ratio
90.91
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Feb 17Expected
Q4 2024
Q1 2025
Q3 2025
Q4 2025
Q1 2026
Q3 2026
Next
-2.86
-0.49
1.89
4.26
Expected EPS
-0.633333
Actual EPS
N/A

Financials

-63.54%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
13.19MRevenue
-8.38MNet Income

Analyst Ratings

$12.00Average Price Target
The highest estimate is ⁦12.00⁩.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PTN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap251.89B
Amgen develops therapeutics in areas similar to Palatin, including reproductive health and cardiovascular diseases, making them direct competitors in the biopharmaceutical market.
Pfizer
PFE
Mkt Cap164.67B
Pfizer competes with Palatin in the development of novel drugs, including treatments in sexual health, where Palatin has a significant focus.
Lilly(Eli) &
LLY
Mkt Cap1.29T
Eli Lilly offers products in men's health and other areas that overlap with Palatin's focus, particularly in treatments for conditions like erectile dysfunction.
Abbvie
ABBV
Mkt Cap521.5B
AbbVie, with its broad range of pharmaceutical products, competes in the same therapeutic areas as Palatin, including women's health and hormonal therapies.
Merck
MRK
Mkt Cap364.26B
Merck operates in various healthcare segments that compete with Palatin, including the development of drugs for sexual health and cardiovascular diseases.
Novartis
NVS
Mkt Cap303.12B
Novartis competes with Palatin in multiple areas, including cardiovascular and metabolic conditions, through its extensive research and development in these fields.
Bristol-Myers Squibb
BMY
Mkt Cap129.66B
Bristol Myers Squibb's diverse range of pharmaceutical products in areas like cardiovascular diseases places it in competition with Palatin Technologies.
GSK
GSK
Mkt Cap101.13B
GlaxoSmithKline has a presence in the sexual health market, making it a competitor to Palatin, especially in the development of treatments for related conditions.
Astrazeneca
AZN
Mkt Cap286.07B
AstraZeneca's work in cardiovascular and metabolic diseases competes with Palatin's research and development efforts in similar therapeutic areas.

About

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
Show More
CEO
Carl Spana
Employees
25
Country
United States
ISIN
US6960776010
WKN
000A3DTUW

Listings

0 Comments

Share your thoughts

FAQs

What is Palatin Technologies stock price today?▼
The current price of PTN is $5.35 USD — it has decreased by -12.65% in the past 24 hours. Watch Palatin Technologies stock price performance more closely on the chart.
What is Palatin Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Palatin Technologies stocks are traded under the ticker PTN.
Is Palatin Technologies stock price growing?▼
PTN stock has fallen by -22.93% compared to the previous week, the month change is a -11.79% fall, over the last year Palatin Technologies has showed a -58.29% decrease.
What is Palatin Technologies market cap?▼
Today Palatin Technologies has the market capitalization of 9.53M
When is the next Palatin Technologies earnings date?▼
Palatin Technologies is going to release the next earnings report on February 17, 2027.
What were Palatin Technologies earnings last quarter?▼
PTN earnings for the last quarter are -1.29 USD per share, whereas the estimation was -0.39 USD resulting in a -233.62% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Palatin Technologies revenue for the last year?▼
Palatin Technologies revenue for the last year amounts to 13.19M USD.
What is Palatin Technologies net income for the last year?▼
PTN net income for the last year is -8.38M USD.
How many employees does Palatin Technologies have?▼
As of November 17, 2026, the company has 25 employees.
In which sector is Palatin Technologies located?▼
Palatin Technologies operates in the Health & Wellness sector.
When did Palatin Technologies complete a stock split?▼
The last stock split for Palatin Technologies was on August 31, 2022 with a ratio of 1:25.
Where is Palatin Technologies headquartered?▼
Palatin Technologies is headquartered in CRANBURY, United States.